Skip to main content

Table 3 Baseline patient complications by geographical region

From: Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study

  All China South Asia East Asia North Africa Middle East Latin America Russia
Patients with macrovascular complications, n (%) 17,806 (27.2) 2,342 (21.3) 4,946 (23.3) 2,685 (26.8) 979 (24.2) 4,293 (28.7) 335 (29.4) 2,226 (72.4)
Patients with microvascular complications, n (%) 35,078 (53.5) 5,467 (49.6) 8,293 (39.0) 5,615 (56.0) 2,397 (59.4) 9,847 (65.8) 715 (62.8) 2,744 (89.3)
Renal disease, n (%) 18,271 (27.9) 2,455 (22.3) 4,321 (20.3) 2,845 (28.4) 1,077 (26.7) 6,108 (40.8) 376 (33.0) 1,089 (35.4)
Eye problems, n (%) 17,198 (26.3) 2,430 (22.1) 3,464 (16.3) 2,380 (23.7) 1,354 (33.5) 5,081 (33.9) 368 (32.3) 2,121 (69.0)
Foot ulcer, n (%) 3,538 (5.4) 274 (2.5) 1,046 (4.9) 536 (5.3) 147 (3.6) 1,289 (8.6) 85 (7.5) 161 (5.2)
Neuropathy, n (%) 25,179 (38.4) 3,671 (33.3) 5,234 (24.6) 3,706 (36.9) 1,530 (37.9) 7,995 (53.4) 491 (43.1) 2,552 (83.0)
  1. Note: due to the observational nature of this study, not all baseline data were recorded.